Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
AIRNA logo — The next generation of RNA editing therapeutics

AIRNA

The next generation of RNA editing therapeutics

Founded 2021 United States Cambridge, United States 84 employees Series B Total: $245.00M Biotechnology, Health Care

General Information

Company Name AIRNA
Founded Year 2021
Location United States Cambridge, United States +2
Founders / Decision Makers
Team member
Employees 84
Industries Biotechnology, Health Care
Funding Stage Series B
Social

Get notified when AIRNA moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About AIRNA

AIRNA, founded in 2021, is a biotech company based in the United States that specializes in RNA editing therapeutics. Their mission is encapsulated in the slogan, "The next generation of RNA editing therapeutics." AIRNA aims to revolutionize health care by offering novel solutions for rare and common diseases through their cutting-edge RNA editing platform, RESTORE+.

The company has recently garnered significant attention, highlighted by a substantial $155.00M Series B investment completed on 01 April 2025. This investment round was led by prominent investors including Arch Venture Partners, Venrock, Forbion, Nextech Invest, RTW Investments, and ND Capital. With this financial backing, AIRNA is well-positioned to advance its innovative pipeline and make substantial progress in the biotechnology and health care industries.

Taxonomy: RNA Editing Therapeutics, Biotech Innovation, Rare Diseases Treatment, Common Diseases Treatment, RESTORE+ Platform, Therapeutic Pipeline Development, Health Restoration, Genetic Medicine, RNA Platform Technology, Novel Therapies, Medical Advancements, Precision Medicine

Services & Products

Development of RNA editing therapeutics
Delivering functional cures through genetic medicine
Optimizing and personalizing treatment solutions

Target Customers

Patients with rare diseases Patients with common conditions Healthcare providers Research institutions

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 6
Investor Investor Investor Investor Investor
•••• •••• 		01 Apr 2025
Series A •••••• 5
Investor Investor Investor Investor
•••• •••• 		01 Jul 2024
Early VC •••••• 5
Investor Investor Investor Investor
•••• •••• 		01 Sep 2023

AIRNA Alternatives & Competitors

View All Alternatives
AIRNA vs
ReNAgade Therapeutics
ReNAgade Therapeutics United States

RNA Without Limits

Series A
24 employees
Biotechnology, Health and Wellness
Compare AIRNA vs ReNAgade Therapeutics
AIRNA vs
Ascidian Therapeutics
Ascidian Therapeutics United States

Rewriting RNA

Series A
48 employees
Biotechnology, Health and Wellness
Compare AIRNA vs Ascidian Therapeutics
AIRNA vs
Autonomous Therapeutics
Autonomous Therapeutics United States

Precision medicines via a new class of RNA

11 employees
Biotechnology, Prop Tech
Compare AIRNA vs Autonomous Therapeutics
View all alternatives

FAQ About AIRNA

The next generation of RNA editing therapeutics
AIRNA was founded in 2021.
AIRNA is headquartered in Cambridge, United States.
AIRNA operates in the following industries: Biotechnology, Health Care.
AIRNA has approximately 84 employees.
AIRNA has completed 3 funding rounds, raising a total of $245.00M. The latest funding stage is Series B.
AIRNA offers: Development of RNA editing therapeutics, Delivering functional cures through genetic medicine, Optimizing and personalizing treatment solutions.
Top alternatives and competitors to AIRNA include ReNAgade Therapeutics, Ascidian Therapeutics, Autonomous Therapeutics, ADARx Pharmaceuticals Inc., Quantum Sky Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AIRNA and ReNAgade Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors AIRNA and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy